Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period

References

• Mitsumoto H, Hanson MR, Chad DA. Amyotrophic lateral sclerosis. Recent advances in pathogenesis and therapeutic trials. Arch Neurol 1988; 45: 189–202.
   Google Scholar
• Dawbarn D, Allen SJ. Neurotrophins and neurodegeneration. Neuropathol Appi Neurobiol 2003; 29: 211–230.
   PubMed Web of Science ®Google Scholar
• Drachman DB, Frank K, Dykes-Hoberg M et al. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2002; 52: 771–778.
   Google Scholar
• Aboussouan LS, Khan SU, Banerjee M, Arroliga AC, Mitsumoto H. Objective measures of the efficacy of non-invasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle & Nerve 2001; 24: 403–409.
   PubMed Web of Science ®Google Scholar
• Desport JC, Preux PM, Truong TC, Vallai JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999; 53: 1059–1063.
   PubMed Web of Science ®Google Scholar
• WHO. The International Classification of Diseases, 8th revision. Geneva: World Health Organization, 1968.
   Google Scholar
• WHO. The International Classification of Diseases, 9th revision, 5th edition. Clinical Modification. Los Angeles, CA: Practice Management Information Corp, 1993.
   Google Scholar
• Brooks BR, Miller RG, Swash M, MunsatTL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Dis 2000; 1: 293–299.
   PubMed Web of Science ®Google Scholar
• Norris FH, Calanchini PR, Fallat RJ, Panchari S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974; 24: 721–728.
   PubMed Web of Science ®Google Scholar
• Armon C, Moses D. Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials Neurol Sci 1998; 160 (Suppl): S37–41.
   Google Scholar
• Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Statist Ass 1958; 53: 457–481.
   Web of Science ®Google Scholar
• Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972; 34: 187–220.
   Google Scholar
• Testa D, Caraceni T, Fetoni V. Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis. J Neurol 1989; 236: 445/447.
   Web of Science ®Google Scholar
• Testa D, Caraceni T, Fetoni V, Girotti F. Chronic treatment with L-threonine in amyotrophic lateral sclerosis: a pilot study. Clin Neurol Neurosurg 1992; 94: 7–9.
   PubMed Web of Science ®Google Scholar
• Beghi E, Chiò A, Inghilleri M et al. A randomised controlled trial of recombinant interferon-beta-la in ALS. Neurology 2000; 54: 469–474.
   Google Scholar
• Kurtzke IF. Risk factors in amyotrophic lateral sclerosis. In: Rowland LP, ed. Adv Neurol Vol 56. New York: Raven Press, 1991: 245–70.
   Google Scholar
• Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle & Nerve 1993; 16: 27–32.
   PubMed Web of Science ®Google Scholar
• Sar M, Stumpf WE. Androgen concentration in motor neurons of cranial nerves and spinal cord. Science 1977; 197: 77–79.
   PubMed Web of Science ®Google Scholar
• Weiner LP. Possible role of androgen receptors in amyotrophic lateral sclerosis: a hypothesis. Arch Neurol 1980; 37: 129–131.
   PubMedGoogle Scholar
• Chancellor AM, Slattery JM, Fraser H, Swingler RJ, Holloway SM, Warlow CP. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 1993; 240: 339–346.
   PubMed Web of Science ®Google Scholar
• Chiò A, Mora G, Leone M et al. Early symptom progression rate is related to ALS outcome. Neurology 2002; 59: 99–103.
   Google Scholar
• Gubbay SS, Kahana E, Zilber N, Cooper G, Pintov S, Leibowitz Y. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. I Neurol 1985; 232: 295–300.
   Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118: 707–719.
   Google Scholar
• Mulder DW, Howard FM Jr. Patient resistance and prognosis in amyotrophic lateral sclerosis. Mayo Clin Proc 1976; 51: 537–541.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Codd MB, Corr B et al. Clinical features of amyotrophic lateral sclerosis according to El Escorial and Airlie House diagnostic criteria. A population-based study. Arch Neurol 2000; 57: 1171–1176.
   Google Scholar
• Norris F, Shepherd R, Denys E et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993; 118: 48–55.
   Google Scholar
• Louwerse ES, Visser CE, Bossuyt PMM, Weverling GJ, The Netherlands ALS Consortium. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. J Neurol Sci 1997; 152(Suppl 1): S10–S17.
   Google Scholar
• Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 2002; 5: 291–309.
   PubMed Web of Science ®Google Scholar
• Iwasaki Y, Ikeda K, Ichikawa Y, Igarashi O, Kinoshita M. The diagnostic interval in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2002; 104: 87–89.
   PubMed Web of Science ®Google Scholar
• Househam E, Swash M. Diagnostic delay in amyotrophic lateral sclerosis: what scope for improvement? J Neurol Sci 2000; 180: 76–81.
   PubMed Web of Science ®Google Scholar
• del Águila MA, Longstreth WT, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis. A population-based study. Neurology 2003; 60: 813–819.
   Google Scholar
• Miller RG, Rosenberg JA, Gelinas DF et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1999; 52: 1311–1323.
   Google Scholar
• Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci 2001; 191: 3–9.
   PubMed Web of Science ®Google Scholar
• Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002; 59: 280–282.
   PubMed Web of Science ®Google Scholar
• Chiò A, Silani V, and the Italian ALS Study Group. Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centres. J Neurol Sci 2001; 191: 145–150.
   Google Scholar